Kazia Therapeutics Director Steven R. S. Coffey Files Initial Beneficial Ownership Statement
Reuters
Mar 19
<a href="https://laohu8.com/S/KZA.AU">Kazia Therapeutics</a> Director Steven R. S. Coffey Files Initial Beneficial Ownership Statement
Kazia Therapeutics reported an initial statement of beneficial ownership for director Steven Coffey. The filing shows direct ownership of 16,000 ordinary shares. It also reports ADS options covering 1,000 ADSs at an exercise price of USD 0.33 and 75,000 ADSs at an exercise price of USD 8.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-114631), on March 18, 2026, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.